Under pressure from Democratic lawmakers and activists, the Joe Biden administration said it will back an effort to
waive intellectual property (IP) protections (WaPo) for COVID-19 vaccines at the World Trade Organization (WTO).
The proposal, brought by a group of developing countries led by India and South Africa in October, would suspend portions of the WTO’s agreement on IP, known as TRIPS, allowing countries to make generic versions of the vaccines. The United States and other wealthy countries initially opposed it. Following Biden’s decision, the European Union announced that it is
willing to engage in discussions (NYT) but did not commit to supporting the effort. Negotiations will continue at the WTO and could take months, as most decisions the body makes must be unanimous. U.S. pharmaceutical companies
opposed the proposal (WSJ), arguing that it could stifle innovation, lead to a shortage of vaccine ingredients, and spur the creation of counterfeit shots.